小剂量低分子肝素治疗妊娠中晚期羊水过少的临床研究

发布时间：2018-06-19 06:22

本文选题：妊娠中晚期 + 羊水过少　；参考：《实用妇科内分泌杂志(电子版)》2016年16期

【摘要】：目的探讨小剂量低分子肝素治疗妊娠中晚期羊水过少的临床效果。方法选取我院2014年6月~2016年6月收治的妊娠中晚期羊水过少患者78例,随机分为对照组与观察组各39例,对照组患者均行常规静脉补液治疗,观察组患者在此基础上给予小剂量低分子肝素治疗。结果观察组患者治疗后羊水指数与脐动脉血流阻力均明显好于对照组,差异有统计学意义(P0.05);同时,观察组孕产妇自然分娩率、新生儿Apgar评分及出生体重均显著高于对照组,差异有统计学意义(P0.05)。结论小剂量低分子肝素治疗妊娠中晚期羊水过少的临床效果较好,不仅能够显著纠正其羊水指数与脐动脉血流阻力,也可明显改善母婴分娩结局。
[Abstract]:Objective to investigate the clinical effect of low-dose low-molecular heparin (LMWH) in the treatment of oligohydramnios in middle and late pregnancy. Methods from June 2014 to June 2016, 78 patients with oligohydramnios were randomly divided into control group (n = 39) and observation group (n = 39). The patients in the observation group were treated with low-dose low-molecular heparin on this basis. Results after treatment, the amniotic fluid index and umbilical artery blood flow resistance in the observation group were significantly better than those in the control group, and the difference was statistically significant (P 0.05). At the same time, the natural delivery rate, neonatal Apgar score and birth weight in the observation group were significantly higher than those in the control group. The difference was statistically significant (P 0.05). Conclusion low dose low molecular weight heparin is effective in the treatment of oligohydramnios in the middle and late stages of pregnancy. It can not only significantly correct the amniotic fluid index and umbilical artery resistance, but also improve the outcome of maternal and infant delivery.
【作者单位】：贵州省习水县人民医院妇产科;
【分类号】：R714.2

【相似文献】